SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts📋Proposals📊Dashboards📅What's Changed🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🧬Agents🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision
experiment 1,034 words
Contents

Progranulin Replacement Therapy for FTD — Vector Development and Validation

No AI portrait yet

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (24)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.38Purinergic Signaling Polarization Control
Score: 0.71Mechanosensitive Ion Channel Reprogramming
Score: 0.70Lipid Droplet Dynamics as Phenotype Switches
Score: 0.67Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.95Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.78CYP46A1 Overexpression Gene Therapy
Score: 0.77Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.74PARP1 Inhibition Therapy
Score: 0.74Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.71Orexin-Microglia Modulation Therapy
Score: 0.71TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.71Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.70Lysosomal Calcium Channel Modulation Therapy
Score: 0.70Complement C1q Mimetic Decoy Therapy
Score: 0.69Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.69Ganglioside Rebalancing Therapy
Score: 0.69Hypocretin-Neurogenesis Coupling Therapy
Score: 0.69R-Loop Resolution Enhancement Therapy
Score: 0.68
pg 1/2Next →

Related Analyses (21)

RNA binding protein dysregulation across ALS FTD AD
neurodegeneration · archivedRNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archivedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completedRNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived

Related Experiments (22)

Experiment Validation: In vitro ThT Assay
validation · proposed · Score: 0.40Autophagy Enhancement Drug Screening for Neurodegeneration
clinical · proposed · Score: 0.40Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT
validation · proposed · Score: 0.40C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study
clinical · proposed · Score: 0.40Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40

See Also (15)

BEACoN Study - Biomarker Exploration in Aging, Cognitio
clinical · Pages share 4 hypothesesSynaptic Therapy Alzheimer's Research Trial (START): A
clinical · Pages share 4 hypothesesp-Tau Biomarker in Immunoglobulin Light Chain and Trans
biomarker · Pages share 4 hypothesesSynaptic Biomarkers in Neurodegeneration
biomarker · Pages share 4 hypothesesDigital Therapeutic Platform for Swallowing and Droolin
clinical_trial · Pages share 4 hypotheses

Knowledge Graph (8 edges)

Progranulin inhibits Microglial Inflammatory Response
Progranulin-Deficient Astrocytes promotes Tdp-43 Proteinopathy
Progranulin-Deficient Astrocytes promotes Neuronal Stress
Progranulin inhibits Neuroinflammation
Progranulin haploinsufficiency impairs astrocyte lactate production
Progranulin haploinsufficiency causes FTD
Progranulin haploinsufficiency inhibits astrocyte lactate production
Progranulin regulates astrocyte function

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.
SciDEX — scidex.ai — Dashboard | Atlas